InvestorsHub Logo
Followers 11
Posts 259
Boards Moderated 0
Alias Born 03/01/2024

Re: Dj56 post# 45259

Thursday, 05/02/2024 1:15:18 PM

Thursday, May 02, 2024 1:15:18 PM

Post# of 48397
You make a very good point. Hence why some would consider this gambling like most OTC or speculative stocks/industries.

Odds of scoring a touchdown in pharma industry is low; RSPI in some sense just needs to get the ball in field goal range.

A recent PR suggested they were waiting to maybe later in the year to pursue further the SCI/ADHD program. OSA program has many others seeking that solution as well as questions around utilizing cannibas or synthetic related compounds. They have given the impression they are doing preclinicals there, but no recent update.

The pain/epilepsy candidate feels just a bit different to me. I think NIH has an important/meaningful task in regards to opioids that bypasses the shenangins within the majority of the political arena. The confidence and excitement, and commentary from outside reputable perspectives in regards to progress with epilepsy and pain on this candidate I think is hard for them to mask. It is hard for retail positions to gauge progress, but I kinda feel they have completed a few first downs and are driving the ball.... IMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News